DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Schmitt C, Adamkewicz JI, Xu J. , et al.
Pharmacokinetics (PK), pharmacodynamics (PD), and PK/PD relationships of emicizumab in persons with hemophilia A (PwHA) with inhibitors from adolescent/adult (HAVEN 1) and paediatric (HAVEN 2) phase 3 studies.
Paper presented at: 11th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), February 7–9, 2018 ; Madrid, Spain
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.